Insulin Lispro - Mix50/50 (Humalog)

Trade Name : Humalog

Eli Lilly and Company

INJECTION, SUSPENSION

Strength 100 [iU]/mL

INSULIN LISPRO Insulin [Chemical/Ingredient],Insulin Analog [EPC]

Delivery Process

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

We’ll Get in Touch

Once we review your request, we’ll send you an estimated price for the medicine within 2-5 days.

Confirmation and Payment

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Product information is meant for

Wholesalers Suppliers Exporters Doctors MOH Tender Supplies Hospitals Brand CROs Comparator Supplies Generic Cooperate Sourcing Individual Patients Indian Institutional Buyers

Disclaimer

Trade Marks displayed in compliance with provisions of: Trademark Act, 1999 u/s 30 and 30 (1) of "Fair use"

GNH India is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of Insulin Lispro - Mix50/50 (Humalog) which is also known as Humalog and Manufactured by Eli Lilly and Company. It is available in strength of 100 [iU]/mL per ml. Read more

Insulin Lispro - Mix50/50 (Humalog) is supplied for Tenders/ Emergency imports/ Un - licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials. Click to know price. Read less

Packaging and Delivery

Validated Cold Chain Shipment

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Inquire directly from our website and get 5% off on any medicine!

About GNH

No data

No data

HUMALOGu00a0Mix50/50 is indicated to improve glycemic control in patients with diabetes mellitus.n
Limitations of Use:
The proportions of rapid-acting and intermediate-acting insulins in HUMALOG Mix50/50 are fixed and do not allow for basal versus prandial dose adjustments.n
HUMALOGu00a0Mix50/50u2122 is a mixture of insulin lispro protamine, an intermediate-acting human insulin analog, and insulin lispro, a rapid-acting human insulin analog indicated to improve glycemic control in patients with diabetes mellitus. ()n
Limitations of Use:
The proportions of rapid-acting and intermediate-acting insulins are fixed and do not allow for basal versus prandial dose adjustments. ()n

No data

See Full Prescribing Information for important administration instructions. ()n
Inject subcutaneously in abdominal wall, thigh, upper arm, or buttocks and rotate injection sites to reduce the risk of lipodystrophy and localized cutaneous amyloidosis. ()n
Individualize and adjust dosage based on metabolic needs, blood glucose monitoring results and glycemic control goal. ()n
Inject HUMALOGu00a0Mix50/50 subcutaneously within 15 minutes before a meal. ()n
Do not administer HUMALOG Mix50/50 intravenously or by a continuous subcutaneous insulin infusion pump. ()n
HUMALOG Mix50/50 is typically dosed twice daily (with each dose intended to cover 2 meals or a meal and a snack). ()n

HUMALOGu00a0Mix50/50 injectable suspension 100u00a0units per mL (U-100) is 50% insulin lispro protamine and 50% insulin lispro, a white and cloudy suspension available as:n
Injectable suspension: HUMALOG Mix50/50 is 100 units per mL (U-100), 50% insulin lispro protamine and 50% insulin lispro available as: ()n

10u00a0mL multiple-dose vialn
3u00a0mL single-patient-use KwikPen (prefilled)n

HUMALOGu00a0Mix50/50 is contraindicated:n

Do not use during episodes of hypoglycemia. ()n
Do not use in patients with hypersensitivity to HUMALOGu00a0Mix50/50 or any of its excipients. ()n

No data

Never share
Hyperglycemia or Hypoglycemia with Changes in Insulin Regimen:
Hypoglycemia:
Hypoglycemia Due to Medication Errors:
Hypersensitivity Reactions: Severe, life-threatening, generalized allergy, including anaphylaxis, can occur. Discontinue HUMALOG Mix50/50, monitor and treat if indicated. ()n
Hypokalemia:
Fluid Retention and Heart Failure with Concomitant Use of Thiazolidinediones (TZDs)

The following adverse reactions are discussed elsewhere in the labeling:n
Adverse reactions observed with HUMALOG Mix50/50 include hypoglycemia, allergic reactions, injection site reactions, lipodystrophy, weight gain, edema, pruritus, and rash. ()n
To report SUSPECTED ADVERSE REACTIONS, contact Eli Lilly and Company at 1-800-LillyRx (1-800-545-5979) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

No data

Drugs that may increase the risk of hypoglycemia: antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analog (e.g., octreotide), and sulfonamide antibiotics. ()n
Drugs that may decrease the blood glucose lowering effect:
Drugs that may increase or decrease the blood glucose lowering effect:
Drugs that may blunt the signs and symptoms of hypoglycemia:

No data

Excess insulin administration may cause hypoglycemia and hypokalemia. Mild episodes of hypoglycemia usually can be treated with oral glucose. Adjustments in drug dosage, meal patterns, or exercise may be needed. More severe episodes with coma, seizure, or neurologic impairment may be treated with intramuscular or subcutaneous glucagon or concentrated intravenous glucose. Sustained carbohydrate intake and observation may be necessary because hypoglycemia may recur after apparent clinical recovery. Hypokalemia must be corrected appropriately n

HUMALOGu00a0Mix50/50 (insulin lispro protamine and insulin lispro injectable suspension) is a mixture of 50% insulin lispro protamine, an intermediate-acting human insulin analog, and 50% insulin lispro, a rapid-acting human insulin analog. Insulin lispro is produced by recombinant DNA technology utilizing a non-pathogenic laboratory strain of . Insulin lispro differs from human insulin in that the amino acid proline at position B28 is replaced by lysine and the lysine in position B29 is replaced by proline. Chemically, it is Lys(B28), Pro(B29) human insulin analog and has the empirical formula CHNOS and a molecular weight of 5808, both identical to that of human insulin. Insulin lispro protamine suspension is a suspension of crystals produced from combining insulin lispro and protamine sulfate under appropriate conditions for crystal formation.n
Insulin lispro has the following primary structure:n
HUMALOGu00a0Mix50/50 vials and KwikPens contain a white and cloudy, sterile suspension of insulin lispro protamine suspension mixed with soluble insulin lispro for use as an injection.n
Each milliliter of HUMALOGu00a0Mix50/50 injection contains insulin lispro 100u00a0units, 0.19u00a0mg protamine sulfate, 16u00a0mg glycerin, 3.78u00a0mg dibasic sodium phosphate, 2.20u00a0mg Metacresol, zinc oxide content adjusted to provide 0.0305u00a0mg zinc ion, 0.89u00a0mg phenol, and Water for Injection. The pH is 7.0 to 7.8. Sodium hydroxide and/or hydrochloric acid may be added during manufacture to adjust the pH.n

No data

Standard 2-year carcinogenicity studies in animals have not been performed with HUMALOGu00a0Mix50/50. In Fischer 344 rats, a 12-month repeat-dose toxicity study was conducted with insulin lispro (a component of HUMALOGu00a0Mix50/50) at subcutaneous doses of 20 and 200u00a0units/kg/day (approximately 3 and 32 times the human subcutaneous dose of 1u00a0unit insulin lispro/kg/day, based on units/body surface area). Insulin lispro did not produce important target organ toxicity including mammary tumors at any dose.n
Insulin lispro was not mutagenic in the following genetic toxicity assays: bacterial mutation, unscheduled DNA synthesis, mouse lymphoma, chromosomal aberration and micronucleus assays.n
Male fertility was not compromised when male rats given subcutaneous insulin lispro injections of 5 and 20u00a0units/kg/day (0.8 and 3 times the human subcutaneous dose of 1u00a0unit insulin lispro/kg/day, based on units/body surface area) for 6 months were mated with untreated female rats. In a combined fertility, perinatal, and postnatal study in male and female rats given 1, 5, and 20u00a0units/kg/day subcutaneously (0.2, 0.8, and 3 times the human subcutaneous dose of 1u00a0unit insulin lispro/kg/day, based on units/body surface area), mating and fertility were not adversely affected in either gender at any dose.n

No data

Advise the patient to read the FDA-approved patient labeling ( and ).

LOG5050-0003-PPI-20191115n

Instructions for Use
HUMALOGn n- (HU-ma-log) Mix50/50u2122
(insulin lispro protamine and insulin lispro injectable suspension)
for subcutaneous use
10 mL multiple-dose vial (100u00a0units/mL)
Read this Instructions for Use before you start taking HUMALOG Mix50/50 and each time you get a new vial. There may be new information. This information does not take the place of talking to your healthcare provider about your medical condition or your treatment.n
Do not share your needles or syringes with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.
Supplies needed to give your injection
Preparing your HUMALOG Mix50/50 dose
Giving your HUMALOG Mix50/50 Injection
Disposing of used needles and syringes
How should I store HUMALOG Mix50/50?
All unopened vials:
After vials have been opened:
Keep HUMALOG Mix50/50 vials, syringes, needles, and all medicines out of the reach of children.
If you have any questions or problems with your HUMALOG, contact Lilly at 1-800-Lilly-Rx (1-800-545-5979) or call your healthcare provider for help. For more information on HUMALOG and insulin, go to www.humalog.com.n
Scan this code to launch the humalog.com websiten
This Instructions for Use has been approved by the U.S. Food and Drug Administration.n
Humalog and Humalog Mix50/50u2122 are registered trademarks of Eli Lilly and Company.n
Revised: 11/2019n
Marketed by: Lilly USA, LLC, Indianapolis, IN 46285, USAn
LOG5050VL-0002-IFU-20191115n

Instructions for Use
HUMALOGn- Arrayn- (HU-ma-log) Mix50/50u2122 KwikPenn- Array
(insulin lispro protamine and insulin lispro injectable suspension)
for subcutaneous use
3 mL single-patient-use pen (100u00a0units/mL)
Read this Instructions for Use before you start taking HUMALOG Mix50/50 and each time you get another KwikPen. There may be new information. This information does not take the place of talking to your healthcare provider about your medical condition or your treatment.n
Do not share your HUMALOG Mix50/50 KwikPen with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.
HUMALOG Mix50/50 KwikPen (u201cPenu201d) is a disposable single-patient-use prefilled pen containing 300u00a0units of HUMALOG Mix50/50.n
People who are blind or have vision problems should not use this Pen without help from a person trained to use the Pen.
How to recognize your HUMALOG Mix50/50 KwikPen
Supplies you will need to give your injection
Preparing your Pen
Priming your Pen
Prime your Pen before each injection.
Selecting your dose
Giving your injection
After your injection
Disposing of Pens and Needles
Storing your Pen
Unused Pens
In-use Pen
General information about the safe and effective use of your Pen
Troubleshooting
If you have any questions or problems with your HUMALOG Mix50/50 KwikPen, contact Lilly at 1-800-LillyRx (1-800-545-5979) or call your healthcare provider for help. For more information on HUMALOG Mix50/50 KwikPen and insulin, go to www.humalog.com.n
Scan this code to launchn
www.humalog.comn
This Instructions for Use has been approved by the U.S. Food and Drug Administration.n
HUMALOG Mix50/50u2122 and HUMALOG Mix50/50u2122 KwikPen are trademarks of Eli Lilly and Company.n
Revised: November 2019n
Marketed by: Lilly USA, LLCIndianapolis, IN 46285, USA
Copyright u00a9 2007, 2019, Eli Lilly and Company. All rights reserved.n
LOG5050KP-0004-IFU-20191115n

PACKAGE CARTON u2013 HUMALOG Mix50/50 10 mL vial 1ct
NDC 0002-7512-01n
10 mLn
100 units per mLn
Humalog Mix50/50u2122ntttttt
insulin lispro protaminen
and insulin lispro injectable suspensionn
For subcutaneous use only.n
Rx onlyn
U-100n
www.humalog.comn
Lillyn

PACKAGE CARTON u2013 HUMALOG Mix50/50 KwikPen 5ct
NDC 0002-8798-59n
Humalog Mix50/50u2122n
KwikPenn
insulin lispro protamine and insulin lispro injectable suspensionn
For Single Patient Use Onlyn
Dispense in this sealed carton.
U-100n
100 units per mLn
Needles not includedn
This device is recommended for use with Becton, Dickinson and Company's insulin pen needlesn
For subcutaneous use only.n
prefilled insulin delivery devicen
Rx onlyn
5 x 3 mL Prefilled Pensn
Read Insulin Delivery Device Instructions for Usen

Browse Our Services And Processes

Comparator Sourcing for Clinical Trials

GNH India brings over 10 years of experience in Comparator

Name Patient Supply

Today, the exact cause for many rare diseases remains unknown

Validated Cold Chain Shipment

With shifting of pharma industry from synthetic molecules to biologic

Clinical Trials Supply

STOP SOURCING..... START SMART SOURCING...... COME STRAIGHT TO THE SOURCE

Dossiers and Stability Studies

STABILITY STUDIES STABILITY, BA / BE STUDIES Due to our active

Pharmaceutical Contract Manufacturing

GNH Provides Contract Manufacturing services for: Generic Medicines with following

Pricing

PRICING POLICY Terms of sales are typically prepaid, unless otherwise

Disclaimer

Please see the Legal Notice for detailed terms and disclaimers. The Legal Notice governs the use of this Website and by accessing and using this Website you agree to be bound by and accept the Legal Notice.

Browse from other international pharmaceuticals

General

64020 Products

GNH India Brings to over 64036 Product SKUs from India all at 1 place with easy access and global deliveries.

US NDC

71247 Products

GNH India Brings to over 71252 Product SKUs from India all at 1 place with easy access and global deliveries.

Canadian DIN

51046 Products

GNH India Brings to over 51047 Product SKUs from India all at 1 place with easy access and global deliveries.

Swiss Drugs

150 Products

GNH India Brings to over 150 Product SKUs from India all at 1 place with easy access and global deliveries.

NZ Drugs

13296 Products

GNH Brings to over 13298 Product SKUs from India all at 1 place with easy access and global deliveries.

FAQ

Check out our delivery process

Can’t find what
you’re looking for?

Get Price

Insulin Lispro - Mix50/50 (Humalog)

Trade Name : Humalog

INJECTION, SUSPENSION

Delivery Process

Product information is meant for

Disclaimer

Trade Marks displayed in compliance with provisions of: Trademark Act, 1999 u/s 30 and 30 (1) of "Fair use"

Packaging and Delivery

About GNH

Similar Products

Desogestrel And Ethinyl Estradiol (Emoquette)

Diphenoxylate Hydrochloride And Atropine Sulfate (Diphenoxylate Hydrochloride And Atropine Sulfate)

Fluoxetine Hydrochloride (Fluoxetine)

Metoprolol Succinate (Metoprolol Succinate)

Losartan Potassium (Losartan Potassium)

Browse Our Services And Processes

Disclaimer

Browse from other international pharmaceuticals

General

US NDC

Canadian DIN

Swiss Drugs

NZ Drugs

FAQ

Can’t find what
you’re looking for?

COMPANY

SERVICES

QUICK LINKS

CONTACT US

Insulin Lispro - Mix50/50 (Humalog)

Trade Name : Humalog

INJECTION, SUSPENSION

Delivery Process

Product information is meant for

Disclaimer

Trade Marks displayed in compliance with provisions of: Trademark Act, 1999 u/s 30 and 30 (1) of "Fair use"

Packaging and Delivery

About GNH

Similar Products

Desogestrel And Ethinyl Estradiol (Emoquette)

Diphenoxylate Hydrochloride And Atropine Sulfate (Diphenoxylate Hydrochloride And Atropine Sulfate)

Fluoxetine Hydrochloride (Fluoxetine)

Metoprolol Succinate (Metoprolol Succinate)

Losartan Potassium (Losartan Potassium)

Browse Our Services And Processes

Disclaimer

Browse from other international pharmaceuticals

General

US NDC

Canadian DIN

Swiss Drugs

NZ Drugs

FAQ

Can’t find what you’re looking for?

COMPANY

SERVICES

QUICK LINKS

CONTACT US

Can’t find what
you’re looking for?